Biotechnology Companies Worldwide
Location
Category
List of Biotechnology companies in All locations
1165 companies
Sort by
We serve a diverse range of clients, including pharmaceutical companies, biotech firms, and academic institutions, accelerating their research and clinical applications through tailored sequencing solutions and expert bioinformatics support. Our CLIA/CAP accreditation and robust quality management systems ensure reliable and reproducible results, enabling breakthroughs in areas such as cancer research, drug development, and personalized medicine.
With a team of experienced healthcare and technology innovators, Revolution MD is at the forefront of medical innovation, committed to safeguarding patient safety and driving a paradigm shift in pain management strategies. We prioritize patient safety through advanced technology and comprehensive care, focusing on prevention and delivering measurable results.
Leveraging a translational research model, we focus initially on animal health, specifically designing a pathway for rapid development and commercialization of therapeutics directly applicable to human infectious disease markets. CYGNOS BioTech’s core expertise lies in peptide chemistry, antiviral drug development, and oncology research, supported by a strong network of collaborators and a commitment to regulatory compliance. With a proven track record of innovation and a strategic approach to drug development, CYGNOS BioTech is poised to make a significant impact on global health.
Nihan Marun, a veterinarian and microbiology Ph.D., Sigma BioVet Sciences combines two decades of global industry experience with a deep understanding of regulatory landscapes across five continents. We translate complex scientific data into clear, actionable insights for companies, veterinarians, legal teams, and pet owners alike. Our core mission is to ensure responsible microbiome development, prioritizing mechanism, data, and precision over speed and marketing trends.
Sigma BioVet Sciences is uniquely positioned to deliver the knowledge and expertise needed to navigate the evolving animal microbiome space, fostering innovation and promoting animal health. We are committed to building a bridge between science, regulation, and the market, ensuring that microbiome-based products are both effective and compliant. We help biotech, pharma, and animal health companies get the science right and keep it compliant.
Our focus areas include microbiome-based therapeutics, biotic product development and claims substantiation, antimicrobial resistance (One Health), regulatory affairs, veterinary professional training, education, and scientific/medical writing.
We serve patients facing aggressive cancers, offering hope for a future where cancer treatment is both effective and significantly less debilitating. Our team combines expertise in oncology, engineering, and business, driving us toward clinical trials and ultimately, life-changing advancements in cancer care. We are committed to translating scientific breakthroughs into tangible benefits for patients worldwide, and our ongoing patent portfolio reflects our dedication to innovation and protecting our transformative technology.
Our core intelligence, the Apex Protocol, utilizes Verified Intelligence Markers (VIMs) and Leadership Velocity Tracking to drive informed decision-making. We specialize in Talent Advisory Consulting, Leadership Architecture Reviews, and C-Suite Assessment, alongside IP Strategy, Regulatory Architecture, Clinical Infrastructure, Executive Search, and Venture Creation. Zenphia’s mission is to de-risk innovation and restore possibility within the life sciences ecosystem, connecting groundbreaking research with successful commercialization.
We are currently seeking early-stage investment to further develop our platform.
Eurofins DiscoverX is a leading provider of innovative cell-based assays and services for drug discovery and development, based in Fremont, California. We empower scientists with trusted solutions to accelerate research and drug discovery programs with confidence. Our comprehensive portfolio includes recombinant GPCR proteins, active cell lines, and ready-to-use assays, supporting applications from initial screening to QC lot release. As the products company of Eurofins Discovery, we’re part of the Eurofins BioPharma global network, contributing to the discovery and development of life-saving therapeutics. We develop and manufacture cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, pharmacotrafficking, and many other applications.
Eurofins DiscoverX serves a global community of researchers and pharmaceutical companies, providing the tools and expertise needed to navigate complex drug discovery challenges. We specialize in supporting a wide range of target families, including GPCRs, kinases, epigenetics, and ion channels. Our commitment to quality and innovation ensures reliable and reproducible results, accelerating the path to new therapies.
What sets Eurofins DiscoverX apart is our integrated approach, combining cutting-edge technology with deep scientific expertise. We offer custom assay development services, alongside our extensive catalog of validated products. Founded in 2000, we’ve built a strong reputation for delivering exceptional value and supporting breakthrough discoveries. With 118 employees across three centers of excellence – Fremont, St. Louis, and Poitiers – we’re dedicated to advancing the future of medicine.
We provide science-backed solutions to help families understand and manage infant food reactivity, offering a trusted alternative to blind elimination diets or relying solely on formula.
Free to Feed™ combines rigorous research with compassionate support, empowering parents with personalized plans and expert guidance. Our innovative allergen detection system, developed by a team of experienced scientists and healthcare professionals, provides valuable insights into breast milk composition, helping mothers make informed feeding decisions.
Founded in 2018 by Dr. Trill Paullin, PhD, Free to Feed™ is committed to advancing maternal-infant health through evidence-based innovation and a dedication to improving the lives of families facing these challenges.
We provide comprehensive solutions for identifying and quantifying constituents and contaminants in substances and raw materials, supporting critical stages of product development and regulatory compliance.
Mass Spec Lab distinguishes itself through its commitment to utilizing state-of-the-art instrumentation and expert methodologies, ensuring timely, accurate, and targeted data for our clients. We offer a range of services including Leachables & Extractables testing, Targeted Screening Analysis, Structural Elucidation, Fingerprinting & Equivalence Testing, and Stability Testing.
Founded in 2014, Mass Spec Lab is a division of InVision Biomedical Group, dedicated to providing custom analytical services to the ophthalmic biomedical device sector and beyond.
Our flagship initiative, Pattern.org, empowers patients to advocate for their care and directly impact cancer research, providing personalized data and treatment options.
Rare Cancer Research Foundation distinguishes itself by focusing on patient-centric research, building the tools and infrastructure to enable patients to drive research and researchers to advance treatment development. We are committed to transforming the landscape of rare cancer care through innovation and collaboration. Pattern.org and the Genomic Sequencing program are key components of our mission.
We specialize in supplying researchers with ethically sourced, non-transplantable human organs and tissues, obtained through a unique network of partnerships with 31 of the 55 CMS-regulated Organ Procurement Organizations (OPOs). This allows us to offer unparalleled access to both healthy and diseased samples, including internal organs, skin, cerebrospinal fluid (CSF), synovial fluid, and processed or snap-frozen tissues.
Novabiosis transforms complex biological material into ready-to-use research solutions, utilizing our expert cell isolation team to produce high-viability primary cells – cryopreserved and rigorously quality-controlled to ensure reproducible, early-stage research. Our services support advancements in cell biology, hepatocyte research, and more.
Founded in 2021 and currently employing 8 staff, Novabiosis is dedicated to expanding the precious gift of organ donation by minimizing discard and accelerating scientific discovery.
We partner with biopharma, nonprofit, and regulatory stakeholders to understand disease impacts, unmet needs, and patient preferences. Our approach centers on providing tailored solutions, including early-stage patient advocacy, regulatory and legislative support, access and reimbursement planning, and patient experience data collection.
Founded in 2022 by Jenn McNary, Richie Kahn, and Jen Shumsky, Canary Advisors combines decades of experience in rare disease clinical development, patient advocacy, and regulatory affairs. We’re committed to translating research into actionable insights that truly benefit patients and their families. We’ve been recognized for our responsiveness, impact, and innovative strategies, consistently prioritizing the patient voice in drug and device development.
Our team provides a range of services, from clinical trial concierge to patient-focused drug development consultancy, ensuring that every project is strategically aligned with corporate objectives and patient needs.
Our FDA-cleared system simplifies and standardizes fat transfer procedures, offering a consistent and affordable alternative to traditional fillers. We’re dedicated to advancing innovative solutions for aesthetics, wound care, and future medical applications, including orthopedic and gastrointestinal surgery.
Syntr’s automated process dramatically improves fat cell viability and repeatability, leading to superior patient outcomes and a streamlined workflow for practitioners. We are currently enrolling patients in a randomized control trial to investigate using autologous microsized fat tissue in the healing of diabetic foot ulcers.
Join our growing network of clinician partners and unlock the potential of microfat.
We are focused on creating transformative therapies for patients suffering from a range of debilitating diseases, including sickle cell disease (SCD), renal diseases, cardiometabolic diseases, and neurodegenerative diseases. Our research and development efforts are centered around oral medications, offering a more accessible treatment option for patients globally.
IMMvention Therapeutix is a venture-funded company dedicated to advancing innovative treatments and improving patient outcomes. We leverage cutting-edge research in molecular biology to address unmet medical needs and bring impactful therapies to market. Our team combines deep scientific expertise with a commitment to patient-centric drug development.
Founded in 2017 and currently employing 13 individuals, IMMvention Therapeutix is rapidly progressing its pipeline of potential therapies, demonstrating significant promise in addressing complex diseases.
We are dedicated to revolutionizing endometriosis care with the development of the first potential disease-modifying therapeutic, ENDO-205, designed to eliminate lesions and associated symptoms – addressing a condition that affects over 190 million women globally.
Our precision peptide technology enables targeted delivery, reducing off-target side effects and offering a non-invasive alternative to traditional diagnostic methods. We are also advancing an investigational imaging diagnostic agent, FemLUNA, for endometriosis and other cancers, representing a new era of precision treatment.
EndoCyclic Therapeutics is committed to transforming patient lives through groundbreaking solutions in women’s health and oncology.
We specialize in providing rapid turnaround times and cost-effective analytical solutions to support early-stage drug development and research. Alera Labs was founded in 2010 to address the needs of smaller companies seeking responsive and budget-friendly analytical services.
Our core expertise lies in method development, validation, impurity identification, biomarker analysis, and bioanalytical testing, utilizing advanced instrumentation such as GC-MS, LC-MS/MS, and ICP-MS. We are committed to delivering high-quality data and accelerating our clients’ projects.
Peanut allergies affect over 2.5% of children in the U.S., triggering life-threatening reactions and imposing a substantial economic burden on families and the healthcare system. Schools routinely prohibit peanut products to mitigate these risks, and the airline industry has implemented similar precautions.
IngateyGen’s approach centers on utilizing CRISPR and gene editing technologies to modify peanut genetics, resulting in hypoallergenic or allergen-reduced peanuts. Furthermore, we are pioneering the development of Self-Stabilizing Natural Peanut Butter and high-protein peanuts as plant-based meat alternatives, responding to growing consumer demand for healthy and sustainable protein sources. Our team, led by Dr. Hortense Dodo and Dr. Koffi Konan, combines expertise in plant biotechnology, immunology, and food science to drive our mission forward.
We connect researchers, businesses, and policymakers to translate groundbreaking discoveries into tangible products and services. Our work spans a diverse range of applications, including pharmaceuticals, nutraceuticals, cosmeceuticals, and aquaculture, contributing to North Carolina’s economic development and global competitiveness.
MBCOI’s unique approach combines a regional focus with international collaboration, facilitating the exchange of knowledge and resources. We are committed to advancing marine biotechnology and creating a sustainable future through scientific innovation. We support a wide array of research areas, including genomics, marine natural products, algae, and waste remediation.
We empower scientific teams and laboratories worldwide to automate workflows and accelerate breakthroughs in both biomedical and business applications.
Vitality Robotics leverages its expertise in AI, robotics, and software development – including our Labtools.AI platform – to deliver tailored solutions that save time and money, ultimately driving impactful and transformative outcomes.
As an AWS services partner, we provide comprehensive support and guidance to our clients, ensuring seamless integration and maximizing the benefits of AI-driven automation.
Millions of lives are lost each year due to sepsis, a leading cause of death worldwide, often stemming from relative or absolute hypovolemia. Our lead product, VBI-S, utilizes a unique mechanism to redistribute nitric oxide, elevating blood pressure in patients who are refractory to standard fluid therapy.
This innovative approach represents a new paradigm in critical care, offering a potential lifeline for patients facing devastating outcomes. We’ve secured backing from venture capital, the US Department of Defense, and the National Institutes of Health, and are currently enrolling patients in a Phase III clinical trial. VBI-S aims to transform treatment outcomes and save countless lives.
We are committed to advancing this technology and bringing a much-needed solution to patients and healthcare providers worldwide.
Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr. Shawn Y. Seong, Hudson Therapeutics, Inc. leverages a strategic approach to enhance therapeutic potential.
Our core strategy involves in-licensing promising assets, adding value through innovative development, and ultimately out-licensing them to maximize their commercialization. We are dedicated to enriching patients’ quality of life through advancements in anti-inflammatory and immunology therapies.
Our technology serves a diverse range of animal sectors, including livestock (cattle, sheep, goats, poultry, swine), companion animals (dogs and cats), and fish/shellfish.
D2Dx™ provides valuable insights for producers, farmers, and veterinarians, enabling informed decisions regarding animal care, nutrition, and treatment. Furthermore, our products are applicable to human and non-human primate research, supporting drug development and vaccine trials.
Founded in 2009, Nano Discovery Inc. is committed to advancing animal health through innovative diagnostic solutions.
Our team combines bioinformatics expertise with advanced computing and AI to deliver transformative insights for life science research. We offer a comprehensive suite of services, including Bulk RNA-Seq Data Analysis & Gene Expression Profiling, Single-Cell & Multi-Omics Data Analysis, and Interactive Data Visualization & Custom Applications.
DataPrudence is recognized for its domain experts, AI-driven insights, and commitment to high-impact scientific research. We’ve contributed to key studies published in JCI Insight and JACC: Basic to Translational Science, demonstrating our ability to accelerate discoveries and provide measurable results. We’re proud to be a Carboctet Brand.
We are focused on transforming endometriosis treatment by targeting the underlying inflammatory mechanisms driving the disease. Our lead candidate, entering Phase 2b trials, is a re-purposed version of the well-established immunomodulator hydroxychloroquine (HCQ), offering a potential first-line treatment option with a strong safety profile.
SLBST Pharma holds issued patents protecting this novel indication and is committed to delivering a cost-effective and impactful solution for patients suffering from this challenging disease. We are dedicated to advancing women’s health through targeted research and development.
We specialize in developing the SonoMatrix platform, a compact and scalable system that utilizes sonication to rapidly and reproducibly process biological samples in plate-scale formats. Our technology is designed to streamline workflows for applications like Next-Generation Sequencing (NGS) and epigenetic analysis, reducing hands-on time and improving consistency.
Triangle Biotechnology’s expertise combines advanced acoustics engineering with molecular biology, allowing us to create custom mechanical sample-prep workflows tailored to specific customer needs. We are dedicated to making high-throughput sample preparation accessible and affordable globally, supporting the evolving demands of the life sciences industry.
Founded in 2019, Triangle Biotechnology currently employs a team of six experts and is headquartered in Durham, North Carolina.
We address some of the most challenging unmet healthcare needs by creating highly effective and targeted therapies. Our approach, which differs significantly from traditional pharmaceutical methods, avoids genome encoding, focusing instead on the structural properties of RNA.
Helixomer’s innovative technology, combined with a dedicated team of experts, is driving advancements in precision medicine and offering a new paradigm for drug development. We are committed to delivering impactful solutions for healthcare heroes.
We specialize in providing secure, long-term sample storage solutions for the life sciences industry, supporting researchers and pharmaceutical companies with their critical data needs.
Lab Vendor distinguishes itself through our commitment to regulatory compliance, comprehensive cold storage equipment offerings – including ULT freezers, laboratory refrigerators, and cryogenic systems – and dedicated support services, encompassing installation, preventative maintenance, and repair. We’re dedicated to ensuring reliable and continuous operation of your vital research infrastructure.
With a nationwide network of strategically located facilities, we offer scalable and flexible storage options to meet the evolving demands of the scientific community.
We design natural or synthetic microbes or microbial consortia to solve complex biological problems. Our flagship product, Extremase, is a proprietary enzyme cocktail that converts non-food plant waste to sugar for ethanol fermentation and biorefining.
What sets MTE apart is our expertise in leveraging non-model biology – studying organisms from harsh environments – to adapt them for industrial applications. We’re focused on creating sustainable solutions for the agricultural and energy sectors, reducing waste, and improving resource utilization. We offer solutions for increasing the rate of anaerobic digestion, the yield of biogas, and for co-production of high-value renewable hydrocarbons.
Founded in 2024, MTE is driven by a team of experienced scientists and engineers dedicated to translating cutting-edge research into real-world solutions. We are committed to fostering a circular bioeconomy and supporting a more sustainable future.
We investigate the complex interactions within microbial communities, focusing on how environmental variables influence their behavior and developing metrics to guide the creation of new collective behaviors. Our research leverages cutting-edge techniques including microfluidics, massively parallel microscopy, and machine learning to understand and manipulate these interactions.
Oliveira Lab’s work supports advancements in areas such as agriculture, biopharma, and industry, with a particular emphasis on shifting microbiome metabolic states and exploring the spatiotemporal behavior of biological networks. We are dedicated to fostering innovation in synthetic biology and creating tools for a more sustainable future.
We focus on creating a revolutionary CYPREX platform, utilizing our patented poly(ester urea) technology to engineer tunable degradation and controlled drug release. This technology addresses critical unmet needs across a range of clinical applications, including regenerative medicine and advanced drug therapies.
Viamer Biosciences is dedicated to advancing the field of bioresorbable technologies, offering a unique approach to improving patient outcomes and therapeutic efficacy. Our commitment to precision and innovation positions us as a leader in the development of next-generation medical devices. Founded in 2017, we are a privately held company with a growing team dedicated to transforming healthcare through advanced biomaterials.
We specialize in supporting leading organizations – including biotech, pharmaceutical, and contract research – in navigating complex regulations and ensuring adherence to GCP, GLP, and cGMP standards. Our experienced consultants deliver comprehensive solutions, encompassing GCP, GLP and cGMP training, quality assurance audits, compliance training, clinical audits, vendor audits, batch record review, SOP writing, and quality systems implementation.
Founded in 2009, ComplianceLogix leverages a global network of seasoned professionals to help clients achieve operational excellence and meet stringent regulatory requirements. We’re dedicated to translating complex regulations into practical, sustainable solutions, ultimately contributing to the development of innovative and life-saving therapeutics.
We provide comprehensive solutions for researchers and clinical trials, managing Leukopaks and purified cells with meticulous quality control from procurement to cryopreservation.
CellSEP distinguishes itself through our extensive donor database, advanced flow cytometry capabilities, and a dedicated team committed to accelerating your research. We offer a robust suite of services, including PBMC processing, cell separation, and clinical trial study support, all backed by 24/7 temperature monitoring and secure logistics.
With locations across the US – Charleston, Austin, Atlanta, Dallas-Fort Worth, and Orlando – and a commitment to innovation, CellSEP is your trusted partner in advancing life sciences.
Company Name | Location | Category | Employees | Website |
|---|---|---|---|---|
Cambridge, United Kingdom (UK) | Information Technology +3 Information Technology, Science and Engineering, Energy, Agriculture and Livestock | 10-20 | https://betterorigin.co.uk/ | |
Dublin, Ireland | Information Technology +1 Information Technology, Science and Engineering | 50-100 | https://www.nuritas.com/ | |
Sofia, Bulgaria | Agriculture and Livestock +2 Agriculture and Livestock, Pets and Animals, Science and Engineering | 50-100 | https://nasekomo.life/ | |
Somerville, United States (US) | Health and Medical +2 Health and Medical, Information Technology, Science and Engineering | 50-100 | https://cellarity.com/ | |
MANASSAS, United States (US) | Information Technology +1 Information Technology, Science and Engineering | 10-20 | https://www.jeevatrials.com | |
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | http://www.seqmatic.com | |
Knoxville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.rev-md.org | |
Miami, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.nuovobiologics.com | |
Cape Coral, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.sigmabiovet.com | |
Baton Rouge, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.oleandermedicaltechnologies.com | |
Seattle Metropolitan Area, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.zenphia.com | |
Ebersberg, Germany | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://eurofinsgenomics.eu | |
Washougal, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://labs.bestfriend.bio/ | |
Fort Lauderdale, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.renegadebc.com | |
Beaverton, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://joinisa.io | |
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.probius.bio | |
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://www.anaspec.com | |
Ontario, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.lyxia.com | |
Worcester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.vitathreads.us | |
Huntsville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.skyangbio.com | |
Secunderabad, India | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | http://www.prathista.com | |
Salt Lake City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.nanoshellcompany.com | |
Ontario, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://www.biomedservicesinc.com | |
Grand Rapids, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.movefactorx.com | |
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 100-150 | http://www.discoverx.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.freetofeed.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.massspeclab.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://rarecancer.org | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://novabiosis.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.canaryadvisorsllc.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.syntrhealth.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.immventionthera.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.endocyclictherapeutics.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.aleralabs.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.ingateygen.com/ | |
Wilmington, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.mbcoi.net | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.vitalityrobotics.com/ | |
Chicago, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.VivacelleBio.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://HudsonTherapeutics.com | |
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.nanodiscoveryinc.com/ | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.dataprudence.com | |
St Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.slbstpharma.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.trianglebio.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.helixomer.com | |
Hamden, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.labvendor.com/ | |
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://mtebiotech.com/ | |
Greensboro, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.oliveiralab.me | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.viamerbiosciences.com | |
St Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.compliancelogix.com | |
Charleston, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://cellseplabs.com |
50/1,165 results
Frequently asked questions
Updated 23 October 2026
What is Enterprise League?
Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.
Is it free to list my company?
Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.
How does verification work, and what does it cost?
Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.
Where does the company information come from?
Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.
How do I claim or correct my company’s profile?
Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.